Literature DB >> 25710668

Alternative pricing strategies for cancer drugs.

Andrea Messori1, Mauro De Rosa2, Luca Pani3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25710668     DOI： 10.1001/jama.2014.17814

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  3 in total

1.  Multi-Indication Pricing: Nice in Theory but Can it Work in Practice?

Authors:  Jorge Mestre-Ferrandiz; Néboa Zozaya; Bleric Alcalá; Álvaro Hidalgo-Vega
Journal:  Pharmacoeconomics       Date:  2018-12       Impact factor: 4.981

2.  Comment on: "Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review".

Authors:  Angelo Claudio Palozzo; Andrea Messori
Journal:  Pharmacoeconomics       Date:  2016-04       Impact factor: 4.981

3.  Cancer Drug Pricing and Reimbursement: Lessons for the United States From Around the World.

Authors:  Daniel A Goldstein; Michal Sarfaty
Journal:  Oncologist       Date:  2016-07-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.